Stock Trading CanaryHONG KONG · DIRECTORS' NOTICES
Extrawell Pharmaceutical Holdings Ltd.
00858 · Healthcare · Drug Manufacturers—Specialty & Generic
Score
Not ranked: no net buying on the exchange by a director in the last 180 days.
Price vs insider buying
0858.HK · HKD● Purchase × Sale ◇ Public disclosure ▥ 15-day cluster ·
Circles and crosses mark trade dates; diamonds below the axis mark later public disclosures. The trade became public on its disclosure date. Prices are nearest-session closes, not insider execution prices. Marker sizes are not compared when values or currencies differ.
Insiders' buying price vs the latest close
Insiders paid 0.0900 HKD a share on average (2 purchase lines, 1 buyer, 2025-12-15 – 2025-12-16). The close on 2026-11-05 was 45.6% below that price.
The latest purchase (2025-12-16) was at 0.0900 HKD; the close was 45.6% below that price.
Prices paid are weighted by shares and taken from the filings; dividends are not counted. Not scored.
Director trades on the exchange
Purchases and sales on the exchange in the last 12 months, as counted in the score.
| Trade date | Filed | Director | Held as | Trade | Shares | Price | Value |
|---|---|---|---|---|---|---|---|
| 2025-12-16 | 2025-12-18 | CHENG Yong | Spouse or child | Bought | 480,000 | HK$0.090 | HK$43.2K |
| 2025-12-15 | 2025-12-18 | CHENG Yong | Spouse or child | Bought | 110,000 | HK$0.090 | HK$9.9K |
Purchases not counted · 5
Director notices of a purchase that the score leaves out, and why.
| Trade date | Director | Why not counted | Shares |
|---|---|---|---|
| 2026-09-03 | Guo Yi | No price given | 70,000,000 |
| 2026-09-03 | CHENG Yong | No price given | 50,000,000 |
| 2026-08-11 | Xie Yi | No price given | 350,000,000 |
| 2019-10-08 | CHENG Yong | Replaced by an amendment | 139,700,000 |
| 2019-10-08 | CHENG Yong | Replaced by an amendment | 139,700,000 |